Lili Yang

New Capabilities

As of September 2026: Leading the research team

UCLA researchers have engineered cord blood stem cells into cancer-fighting T cells that can be mass-produced, frozen, and used off the shelf. In mice with ovarian cancer and melanoma, a single dose controlled tumors and extended survival without the graft-versus-host disease that plagues donor-derived cell therapies.

Updated Sep 11